Loading...
01/11 03:33
Loading...
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call presents a mixed outlook. While there are positive developments like increased gold sales and a strong cash position, concerns remain about the reliance on feasibility studies, debt strategy, and gold price volatility. The Q&A revealed uncertainties in timelines and management's vague responses, tempering optimism. The neutral rating reflects the balance of positive financial metrics and potential risks, with no significant catalysts to drive a strong stock price movement.
Gold sales Gold sales totaled approximately 8,400 ounces for the quarter, an increase over the prior year period. Total revenue from gold sales increased to approximately $28 million for the quarter, driven by higher ounces sold and a higher average realized gold price of $3,301 per ounce.
Net loss The company concluded the quarter in a net loss position of $0.05 per share, primarily due to the ramp-up and development stage of operations.
Cash position Cash position was approximately $134 million at the end of the second quarter, a significant increase from the previous quarter due to the net proceeds received from the bought deal public offering and private placement, partially offset by settling the gold and silver deliveries under the prepaid instruments for approximately $42 million.
Growth spend For 2025, the company targets $40 million to $50 million in growth spend across permitting, feasibility studies, and the development of Archimedes underground.
Granite Creek Underground: Mining volumes increased compared to the prior year, with approximately 24,000 tons of oxide material mined at 11.4 grams per tonne gold grade and 11,200 tons of sulfide material at 7.4 grams per tonne. Approximately 6,000 ounces of gold were sold in Q2 2025.
Lone Tree Processing Facility: Refurbishment study expected in Q4 2025. The facility is expected to increase gold recovery rates from 55%-60% to approximately 92%, translating to an additional $1,000 per ounce.
Archimedes Underground: Upper level permitting is nearly complete, with development of the underground exploration drift scheduled to commence soon. Infill drilling of the Upper Zone is expected to start in Q4 2025.
Cove Project: Major permit applications are advancing, with an EIS planned for completion by the end of 2027. A feasibility study is targeted for Q1 2026.
Mineral Point Open Pit: Drilling began in June 2025 to collect baseline technical data. Strategic reviews are underway to determine the timing of a pre-feasibility or feasibility study.
Gold Production Growth: Targeting an increase in annual gold production from less than 50,000 ounces to 150,000-200,000 ounces by 2028, 300,000-400,000 ounces by 2030, and over 600,000 ounces by 2032.
Dewatering Program: Proactive long-term measures include additional surface dewatering wells and upgrades to water treatment facilities to support Granite Creek development.
Drilling Programs: 2025 drill program includes over 40 holes at Granite Creek and 175 holes at Archimedes, with results feeding into feasibility studies.
Environmental, Health, and Safety Systems: Industry-leading systems and strong local community relationships are in place.
Recapitalization Plan: Raised $186 million in May 2025 through equity offerings, with potential for an additional $130 million from warrants. Targeting a new senior debt facility of $350-$400 million by mid-2026.
Non-Core Asset Sales: Pursuing the sale of the FAD project and a potential royalty sale on Mineral Point to fund development plans.
Equity Raise and Recapitalization: While the equity raise strengthens the balance sheet, there is a risk of dilution for existing shareholders and potential challenges in meeting the expectations tied to the recapitalization plan.
Development of Lone Tree Autoclave: The refurbishment of the Lone Tree autoclave is critical to the company's strategy, but delays or cost overruns in this project could significantly impact financial performance and timelines.
Dewatering Challenges at Granite Creek: Higher-than-expected levels of oxide mineralized material and groundwater inflows require additional dewatering infrastructure, which could increase costs and delay development.
Permitting and Regulatory Risks: Permitting processes for projects like Archimedes and Cove are complex and time-consuming, with potential delays impacting project timelines and financial outcomes.
Dependence on Feasibility Studies: The company's growth plans rely heavily on the successful completion of multiple feasibility studies, any of which could face delays or yield unfavorable results.
Funding and Debt Strategy: The company plans to secure a new senior debt facility of $350-$400 million by mid-2026. Failure to secure this funding could jeopardize development plans.
Gold Price Volatility: The company's financial performance is highly sensitive to fluctuations in gold prices, which could impact revenue and profitability.
Operational Ramp-Up Risks: The ramp-up of personnel and operations to meet growth targets may face challenges, including hiring delays or operational inefficiencies.
Environmental and Community Relations: While the company has strong environmental and community relations, any misstep could lead to reputational damage or regulatory hurdles.
Gold Production Targets: The company plans a three-phase production increase, targeting over 600,000 ounces of gold annually by the early 2030s. Phase 1 aims to increase production to 150,000-200,000 ounces by 2028, Phase 2 to 300,000-400,000 ounces by 2030, and Phase 3 to over 600,000 ounces by 2032.
Granite Creek Underground Development: The company expects to complete a feasibility study for Granite Creek by Q1 2026. Dewatering infrastructure upgrades are underway to support long-term development.
Archimedes Underground Development: Development of the underground exploration drift is scheduled to begin in the coming weeks, with infill drilling of the Upper Zone starting in Q4 2025 and the Lower Zone by Q1 2026. A feasibility study is targeted for Q1 2027.
Cove Project: Major permit applications are advancing, with an Environmental Impact Statement (EIS) planned for completion by the end of 2027. A feasibility study is targeted for Q1 2026.
Lone Tree Processing Facility: A refurbishment study is expected in Q4 2025, with commissioning planned to provide increased processing capacity and recovery rates for refractory material.
Mineral Point Open Pit: Drilling began in June 2025 to support initial permitting and technical studies. Strategic reviews are underway to determine the timing of a pre-feasibility or feasibility study.
Financial Guidance: The company targets $40-50 million in growth spending for 2025 and plans to allocate over $90 million through mid-2026 for development across all projects. A new senior debt facility of $350-400 million is expected to be in place by mid-2026.
The selected topic was not discussed during the call.
The company's financial performance shows improvement with increased gold sales and revenue, but continued net losses and reliance on securing financing pose risks. The strategic plan outlines ambitious growth targets, but operational and environmental challenges could impact execution. The Q&A revealed uncertainties in management's responses, particularly around asset divestment and oxide ore processing. While there are positive aspects such as strong revenue growth, the risks and uncertainties balance the sentiment, leading to a neutral outlook for the stock price over the next two weeks.
The earnings call presents a mixed outlook. While there are positive developments like increased gold sales and a strong cash position, concerns remain about the reliance on feasibility studies, debt strategy, and gold price volatility. The Q&A revealed uncertainties in timelines and management's vague responses, tempering optimism. The neutral rating reflects the balance of positive financial metrics and potential risks, with no significant catalysts to drive a strong stock price movement.
The earnings call reveals several concerning aspects: a significant EPS miss, balance sheet constraints, and recapitalization risks. Despite increased revenue and a working capital facility, financing challenges and regulatory delays loom. The Q&A session highlighted management's lack of clarity on economic studies. These factors, coupled with the company's reliance on gold prices, suggest a negative sentiment, likely leading to a stock price decline in the range of -2% to -8% over the next two weeks.
The earnings call summary reveals several concerns: balance sheet constraints, regulatory and financing risks, and a net loss position. The Q&A section further highlights unclear management responses, particularly regarding economic studies, which could erode analyst confidence. Despite some positive aspects, such as increased gold sales and a working capital facility, the overall sentiment is negative due to significant risks and uncertainties, particularly around financing and project timelines.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
